Air Ambulance Services Market Global Analysis, Opportunities and Forecast To 2025

The global air ambulance services market is expected to reach USD 8.2 billion by 2025, according to a new report by Grand View Research, Inc. Increasing incidents of life-threatening diseases, such as cardiovascular disorders, that require emergency medical response support the lucrative growth of the market over the forecast period. In addition, increasing awareness about air medical transport services also spurs growth of this market. Furthermore, Availability of reimbursement in developed countries, such as the U.S., helps people avail these services despite the high cost.

                                     View summary of this report, Click Here

Improving global economy led to increased spending, which resulted in increased spending on healthcare. The per capita healthcare expenditure has increased exponentially over the last couple of decades. This per capita health expenditure increased by about 55.0% from 1996 to 2014 as published by The World Bank Group. As a result, the demand for these services has been increasing over the forecast period.

This industry is capital intensive, yet there exhibits constant entry of new players, which has helped maintain the supply-demand balance in fierce market place. For instance, in 2012 there were more than 300 players operating in this space with around 1,300 aircrafts, and this number is likely to increase over the forecast period.

Further key findings from the study suggest:

• Rotary-wing air ambulance services, which include helicopter-based services, held a lucrative share in 2015. Easy usability of helicopters and low cost of these services governed their dominance.
• Fixed-wing services include specialized aircrafts having medical facilities and dedicated crew. Rising medical tourism and operability of these aircrafts in adverse weather conditions are few reasons for their increased demand.
• Hospital based service dominated service model segment in 2015 and also anticipated to grow at healthy rate over the forecasts period.
• North America dominated the global air ambulance market in 2016 due to established infrastructure for air medical transport.
• Asia Pacific is anticipated to gain lucrative share over the forecast period. Strengthening economy, especially of countries such as India and China, investments from global conglomerates, and improving business opportunities are likely to provide growth avenues for players.
• Some of the key players in this vertical include AMR; PHI Air Medical; Scandinavian Air Ambulance; IAS Medical; Express AirMed Transport; Native American Air Ambulance; Lifeguard Air Ambulance, REVA Air Ambulance and Acadian.
• Strategic initiatives undertaken by these players include collaboration, service portfolio expansion, and partnerships with business firms & sports and entertainment events.

For Sample Request Send Us Here : https://goo.gl/yecS1f

Rising incidences of sports related injuries worldwide is anticipated to be high impact rendering driver for the lucrative growth of sports medicine market

The global sports medicine market is expected to reach USD 12.5 billion by 2025, according to a new report by Grand View Research, Inc. Rising incidences of sports related injuries worldwide is anticipated to be high impact rendering driver for the lucrative growth of sports medicine market.

As per data published by the U.S. Consumer Product Safety Commission’s National Electronic Injury Surveillance System (NEISS) in 2012, around 1.9 million people encountered such injuries. Additionally, with aid of fitness awareness initiatives from government and health organizations, people nowadays are more focused on physical exercise including gym, outdoor sports and others fitness activities. With this people are more prone to injuries, hence contributing to the remunerative growth of market.

Additionally, influx of technologically advanced products such as minimally invasive surgical products is anticipated to increase the demand for these devices over the forecast period. For instance, in March 2015, Smith & Nephew launched Q-FIX implant which assists surgeon’s flexibility for all sutures anchors along with fixation and pull-out strength equivalent to large sized anchors.

Similarly, in May 2014 Smith & Nephew acquired ArthroCare, a medical device company based in the U.S. specialized in tissue repair devices. This acquisition helped the company to enrich its sports medicine product portfolio.

View summary of this report, Click Here 

Further key findings from the study suggest:

• Body reconstruction and repair devices consisting of surgical equipment, soft tissue repair, and bone reconstruction devices held significant share in 2016 and also this segment is anticipated to exhibit lucrative growth rate over the forecast period.
• Knee-related applications held largest market share in 2016.The knee injuries are the most frequent in most of the games such as soccer, basketball, bicycle, and running which supported the dominion in application segment.
• In the therapeutic segment, cardiology, IVD, and drug delivery are the top performing segments. Rising incidences of cardiac failures, infectious diseases and high research activity in the field of drug delivery are certain vital impact rendering factors.
• North America, held commanding shares in global sports medicine market. Improved healthcare infrastructure and high healthcare expenditure are key factors responsible for growth. In addition, presence of organizations which are dedicated in field of sports medicine such as the American College of Sports Medicine (ACSM) facilitated availability of adequate and qualified staff.
• The key players of the industry include Stryker Corporation, Arthrex, ArthroCare, Tornier N.V., Wright Medical Technology, DJO Global, Otto Bock Healthcare, Ossur HF, Zimmer Holdings Inc., and Smith & Nephew Plc.

Click Here Access Full Report : https://goo.gl/kCS43w

Rising number of diabetic population and awareness level regarding the usage of insulin pens are key factors to growth pen needle market

The global pen needles market is expected to reach a value of USD 4.8 billion by 2025, according to a new report by Grand View Research, Inc. Rising prevalence of diabetes is the primary reason for the significant growth of pen needles market. According to the International Diabetes Federation (IDF), nearly 415 million people were suffering from diabetes in 2015. Such a high prevalence of diabetes across the globe has led to rising demand for pen needles. Patients suffering from diabetes commonly use injectable pen devices, which helps in easy drug delivery.

In addition, obesity is a significant cause of diabetes. Obese people often suffer from type 2 diabetes, which makes them one of the highest revenue contributors of the target market. Thus, people with type 2 diabetes are the common target population for companies manufacturing pen needles.

Rising technological advancements is also expected to drive the market growth. Pen needles allow comfort and easy mode of insulin delivery. These devices are technologically advanced and provide a superior alternative drug delivery method in comparison to syringes and vials. For instance, in 2013, Becton, Dickinson and Company launched BD Ultra-Fine Nano 4mm Pen Needles with EasyFlow Technology, which will enable diabetic patients with easy adherence of insulin therapy regimens.

View summary of this report, Click Here 

Further Key Findings from the Study Suggest:

• Standard needles dominated the market in 2015 due to the availability of cost-effective needles as compared to safety needles
• Safety pen needles are anticipated to showcase lucrative growth over the forecast period due to the continuous technological advancements
• Amongst the needle lengths, 8mm held the largest share in 2015. This is due to the convenience offered by this needle type on diabetic patients
• Needle length of 4mm are expected to witness attractive CAGR over the forecast period owing to its short length
• Insulin therapy accounted for the largest market share in 2015 due to rising awareness regarding self-administration of insulin amongst the diabetic patients
• Europe dominated the market in 2015 followed by North America owing to high prevalence of diabetes in the European region
• Asia Pacific region is anticipated to exhibit the highest growth rate over the forecast period owing to the rising awareness levels amongst the diabetic population regarding easy drug delivery
• Some of the key players include Becton, Dickinson and Company, B. Braun Melsungen AG, Novo Nordisk A/S, Owen Mumford, Ltd., Ypsomed, HTL-STREFA, and TERUMO CORPORATION.

Click Here For Access Full Report : https://goo.gl/XWXcc2

North America OTC hyaluronic acid (HA) market is expected to reach a value of USD 41.3 billion by 2024

The increasing number of obese people owing to the lack of physical activity and higher consumption of fast food & alcohol, especially by the younger population are some of the factors accounting for growth.

View summary of this report, Click Here 

Orthopedic applications of HA are expected to emerge as the most lucrative segment of this market. This can be attributed to the growing target audience above 60 years, suffering from various joint disorders such as rheumatoid arthritis and osteoarthritis coupled with the introduction of new products catering to this population subset. In addition, increase in the number of arthritis-related hospitalization cases and growing awareness amongst the healthcare professionals regarding excellent physiochemical properties of hyaluronic acid is expected to drive the demand. However, the dermatology segment in the U.S. was the largest segment in 2015 accounting for almost 95.2% of the total U.S. OTC hyaluronic acid market. The growing population of women between 20 and 65 years of age and increasing awareness regarding the benefits of HA are some of the crucial factors driving the surging demand for hyaluronic acid in dermatological procedures.

Hyaluronic acid (HA) stimulates the synthesis of a protein that plays a crucial role in supporting skin structure and collagen, which declines with age leading to wrinkle formation. The growing demand for HA as a topical skin cream or serum coupled with the increasing presence of market participants in this sector is indicative of future growth. The rising awareness regarding the benefits of HA in skin care products for penetrating the dermis more effectively as compared to collagen is also anticipated to propel the market trend. According to various reports, approximately 27% of the total U.S. women population belong to the age group of 45 to 65 years, which is one of the crucial factors responsible for the surging demand for anti-wrinkle creams.

Some of the key players are Shiseido Co., Ltd.; Lindberg Nutrition & GeniusCentral Systems; Nature’s Way Products, LLC; NOW Foods; NeoCell Corporation; Source Naturals, Inc.; Doctors Best; derma e; and Earth Science Naturals

Click Here For Access Full Report : https://goo.gl/zog9y3

Breast Implants Market Growth Is Anticipated To Reach USD 2.0 Billion By 2025

Increasing focus toward enhancement of physical appearance has led to the growth of breast implants market.

Breast reconstructions are being highly adopted by women in order to enhance their physical appearances. This kind of surgery involves esthetic repair of any damage taking place after implantation procedure. According to the American Society of Plastic Surgeons, in 2015, nearly 106,000 breast reconstruction procedures have been performed in the U.S. Thus, such huge number of cases are expected to drive the growth of the market.

Breast implants are used post mastectomy to enhance esthetic appeal. Breast augmentation is another procedure requiring the application of these implants. Esthetic appeal plays an important role in increasing the demand for these procedures, thereby, making the cosmetic industry lucrative for the target population.

View summary of this report, Click Here 

Further key findings from the study suggest:

• In 2016, silicone implants dominated the market due to the fact that it has a natural resemblance to the breast tissue
• Saline implants are anticipated to showcase significant growth over the forecast period due to lesser risk of complications during implant rupture
• Round-shaped implants held the largest market share in 2016 owing to less complications involved during implant rotation
• Anatomical-shaped devices are expected to showcase lucrative growth in the future due to their design that has a natural appearance, which make them ideal for breast enhancement
• The cosmetic surgery segment dominated the market in 2016 due to the growing number of cosmetic procedures conducted globally
• North America dominated the market in 2016 due to rising number of augmentation procedures of this organ conducted in the U.S.
• Asia Pacific is expected to display lucrative growth over the forecast period owing to immense opportunities in the field of medical tourism in this region
• Some of the key players include ALLERGAN; Sientra, Inc.; GC Aesthetics; Mentor Worldwide LLC; Establishment Labs S.A.; Polytech Health & Aesthetics GmbH; GROUPE SEBBIN SAS; HANSBIOMED CO. LTD; Laboratoires Arion; and Shanghai Kangning Medical Supplies Ltd.

Click Here For Access Full Report : https://goo.gl/4s8DSz

Trauma and extremities market worth is expected to reach a value of USD 15.9 billion by 2024

The expansion is attributed to the increasing geriatric population base along with the growing incidence rate of target diseases such as osteoporosis.

Introduction of new technologies in terms of material, technique, and the non-invasive nature of the employed material are augmenting the market growth. In July 2016, DePuy Synthes launched a new hand locking system used for deformities and fracture fixation. This device is designed to reduce soft tissue irritation and facilitate healing.

Moreover, companies are investing in new product development, which is anticipated to aid the future growth of the market. In 2015, Smith & Nephew invested USD 222 million on research and development, yielding a promising product pipeline for 2016. It has already launched a new product, SUTUREFIX, a suture anchor in February 2015. The product is expected to improve hip and shoulder repair by providing additional fixation points.

The industry is dominated by few players, while local implant manufacturers share the remaining market. DePuy Synthes, Stryker, Zimmer Biomet, and Medtronic and others are key players while Advanced Orthopedic Solutions, Emerge Medical, and Bioretec Ltd. are the emerging players in this vertical.

View summary of this report, Click Here 
Further Key Findings From the Study Suggest:

• Internal fixation dominated the market in 2015 due to the following associated advantages: shorter hospital stay, lesser scars and skin pressure, early functionality achieved in patients, and lesser risk of nonunion and malunion of bones. Industry players are adding new products with better functionality, which replicate the native anatomy, enhancing both, functionality and durability. In July 2016, the Acumed’s wrist fixation implants, Acu-Loc and Acu-Loc 2, reached a worldwide sales milestone of 0.5 million in 2 years. This indicates the high demand for internal fixation devices, which is expected to grow over the forecasted period.
• Amongst internal fixation methods, plates and screws are the most popular owing to the less blood loss involved and shorter operative time. This segment is expected to witness growth owing to the focus of companies on integrating different tools into one system. For instance, in July 2016, DePuy launched its locking hand system comprising 40 basic and specific plates for different cases of hand fractures. This aids the surgeons in adjusting the insertion specific to the patient’s bone anatomy to provide more stability.
• In 2015, North America dominated the market with a revenue share of more than 40%. The Affordable Care Act includes a separate grant for trauma care. Though this fund was discontinued in 2006, it was reauthorized in 2014 and set to an annual USD 12 million. The fund allocation aimed the improvement of trauma care centers in terms of access and quality, especially in the rural areas.

Click Here For Access Full Report : https://goo.gl/rCIesi

Clinical Microbiology Market Growth Is Expected To Reach A Value Of USD 16.1 Billion By 2024

Key factors driving the market growth include constant introduction of advanced products coupled with increasing demand in pharmaceutical, and clinical applications for investigation and diagnosis of various infectious diseases.

The market is rapidly growing due to the increasing adoption of automated and advanced technologies for laboratory instruments and analyzers in developed countries. Growing geriatric population and thereby rising prevalence of infectious diseases is one of the major factors boosting the adoption of clinical microbiology in healthcare sector for disease diagnosis and monitoring. In addition, industry is gaining high momentum with launch of innovative products such as MALDI Biotyper, GeneXpert and Myla IT performance management solutions. Moreover, with the U.S. FDA approving the Xpert Carba-R, commercialization of clinical microbiology devices is expected to increase significantly over the next few years.

In North America, the government authorities and private companies have significantly contributed toward technology development, research funding, and commercialization of clinical microbiology associated devices.

View summary of this report, Click Here 

Further Key Findings from the Study Suggest:

• Rapid adoption of technology and automation of laboratory work flow, laboratory instrument segement is expected to be the fastest growing segment with CAGR of 8.6% over the forecast period.
• Reagents is the largest segment with market share of 34.7% in 2015. Repeat purchase of reagents contribute to its growth thus it is the largest growing segment in market.
• In 2015, North America dominated the global market with largest revenue share of 41.0%. The continuous research on infectious disease treatment, and subsequent grant from government healthcare agencies are contributing to the development of a strong ecosystem for the expansion of clinical microbiology in the region.
• Asia Pacific is expected to emerge as the fastest growing region during the forecast period. The growing geriatric population in India, China and Japan leading to increase in the prevalence of re-emerging infectious diseases such as tuberculosis, cholera and typhoid in this region are expected to promote the utilization of clinical application of microbiology in healthcare.
• The clinical microbiology Industry is presently dominated by a few key participants such as bioMerieux S.A., Cepheid Inc., Danaher Corporation and Bruker Corporation. Some of the prominent players operating in the market include but are not limited to Becton Dickinson & Company, Hologic Inc., Roche Diagnostics and Alere Inc. Introduction of automated systems and innovative designs, is expected to intensify the competition by changing the market dynamics over the forecast period.

Click Here For Access Full Report : https://goo.gl/k18t1S

Electrodes For Medical Devices Market Growth Is Expected To Reach USD 2.0 Billion By 2025

The market is anticipated to witness lucrative growth during the forecast period, owing to increasing prevalence of chronic and other diseases such as heart diseases, Parkinson’s Disease (PD), Alzheimer’s disease, brain disorders, Trigeminal Neuralgia (TN or TGN), sinusitis, tinnitus, Raynaud's disease, fibromyalgia, circulatory disturbances, gout, and body ache, across the globe. 

Minimally Invasive Surgery (MIS) is one of the advancements in medical technology in which small incisions are made in the body for laparoscopy, endoscopy, arthroscopy, and other surgical procedures. This procedure is gaining popularity owing to faster recovery, lesser postsurgical infections, pain, & major bleeding, reduced scarring, and high accuracy benefits. In 2015, over 20.0 million Americans underwent MIS, which is expected to assist in the growth of this vertical during the forecast period.

View summary of this report, Click Here 

Further Key Findings From the Study Suggest:

• The diagnostic segment held a profitable revenue share in 2016 and is expected to grow at a significant rate over the forecast period.
• Rising prevalence of heart diseases, fetal distress syndrome, ocular diseases, and neurological disorders make extensive use of Electrocardiogram (ECG), Electroencephalogram (EEG), electrosurgical, and fetal scalp electrodes
• The therapeutic segment is anticipated to witness the fastest growth over the forecast period due to widened use of medical electrodes in aesthetic surgeries, RF ablation procedures, neurosurgical procedures, and acute & chronic pain treatments
• Defibrillator and electrosurgical electrodes are projected to hold substantial market share over the forecast period. This can be attributed to the advanced development of wearable defibrillator that constantly monitors the cardiac rhythms of the wearer and identifies & notifies the user about the occurrence of any abnormality and helps regain the normal heart functionality
• North America is expected to dominate the medical electrodes market during the forecast period, owing to the rising prevalence of CVDs, changing lifestyle of individuals, and presence of target population in the U.S. and Canada. In addition, the presence of advanced technologies with electrodes such as hydrogel and dry electrodes in the region are expected to spur the medical electrodes market growth.
• Some of the key players in medical electrodes market are 3M Healthcare; Boston Scientific Corporation; GE Healthcare; C.R Bard Inc.; CONMED Corporation; Medtronic; Natus Medical Incorporated; Thermo Fisher Scientific Inc.; Asahi Kasei Corporation; and Philips Healthcare

Click Here For Access Full Report : https://goo.gl/nVmyOV

Global Biological Implant Market Is Anticipated To Reach USD 9.8 Billion By 2024

Biological implant market is driven by rise in adoption of grafts and organ substitutes for reconstructive surgeries for various clinical applications such as cardiovascular, orthopedic and other soft tissue repair. The main challenge associated with the use of these products is to incorporate such a material that can specifically adapt to the biology of the surrounding environment in order to accelerate regeneration and repair. To overcome this challenge, research endeavors are carried out in order to develop such devices from biological source thus affecting industrial growth in the coming years.

Modification in the process of composite grafting is expected to play a crucial role in tackling reimplantation of amputated fingertips by bringing development in the overall process of grafting. Moreover, rising competition amongst key participants operating in this market is one of the high impact rendering factors to accelerate the growth.

View summary of this report, Click Here 

Further key findings from the report suggest:

• Depending upon the source or donor of grafts, products offered can be categorized into autograft, allografts, and xenografts. Xenografts dominated the revenue share in 2015 with a revenue share of over 50%. However, allografts are expected to witness the fastest growth owing to the fact that they are derived from same species and produce considerably less chances of foreign immune reaction, thereby influencing adoption rate.
• Biological implants serve various application domains which include cardiovascular, orthopedic, and other soft tissue implants. Soft tissue products accounted for the largest share in 2015 as a result of higher usage of the products in the field of dentistry. Even though cardiovascular implants accounted for lowest penetration in the current scenario, demand for cardiovascular stents and valves obtained from biological source is expected to expand, consequently boosting revenue generation from this segment.
• Amongst surgical and injectable mode of administration, surgical mode is estimated to hold the larger share, as a consequence of availability of several products administered via this route. Introduction of minimally invasive techniques for surgical incorporation of grafts is also one of the significant factors propelling growth in this segment.
• North America dominated the market with a revenue share of 50% due to widespread presence of participants coupled with high aesthetic and healthcare awareness levels amongst the population in this region.
• Asia Pacific is estimated to exhibit the fastest growth in the coming years due to presence of the target population and rapidly improving health care infrastructure which is attributed to drive the demand for tissue engineered products and biological implants.
• Major players operating in this industry include Medtronic, NuVasive, Inc, Stryker Corporation, Conmed Corporation, CryoLife, Edwards LifeSciences Corporation, Acelity, Integra LifeSciences Corporation, Allergan Plc, RTI Surgical, IOP Ophthalmics, Organogenesis Inc, BioPolymer GmbH & Co. KG, Osiris Therapeutics, Baxter International, Vericel, Aplhatec Spine Inc, Maxigen Biotech Inc, Auto Tissue Berlin GmbH, MiMedx Group, Inc., Biotissue Technologies,
• These players are undertaking different business strategies to boost their respective penetration and enhance market presence. These strategies include novel product developments and geographic expansion by involving in collaborative activities in order to grab the larger share of revenue. For instance, in April 2016, Stryker Corporation acquired Stanmore Implants Worldwide Limited which is expected to enable the company to provide differentiated technologies to orthopedic oncology surgeons, thus propelling growth over the forecast period.

Click Here For Access Full Report : https://goo.gl/FoKJKV

Automated Dispensing Machine Market Is Expected To Reach A Value of USD 5.5 Billion By 2024

The growing pressure on the pharmaceuticals due to reimbursement reduction and rapidly growing drug prices leads to inefficient supply chain and inventory management. The growing demand for automated systems, such as RFID cabinet and barcodes, facilitates real-time inventory and stock management, which is one of the pivotal factors expected to drive the market in the coming years.

Furthermore, the increase in global geriatric population and prevalence of various chronic diseases, as well as high rates of hospitalization are some of the factors increasing the burden on pharmacy of hospitals and retail drug stores. Upsurge in number of prescriptions and lack of skilled pharmacist are also few factors expected to boost automation in the medication dispensing system.

There is increasing demand for technologically advanced medication dispensing systems to mitigate long waiting hours for stock replenishment and drug mismanagement, which is one of the crucial factors expected to drive the usage rate of pharmacy automation system, such dispensing, storage, and retrieval. Based on the 2011 ASHP national survey of pharmacy practice in hospital settings, it was stated that approximately 89% of the hospitals are using automated dispensing cabinets and over 10% of the hospitals are using robots.

According to a survey conducted by Society of Actuaries, it was found that measurable medication errors cost USD 20 billion to the U.S. economy, while majority of these errors could have been easily avoided. Increase in medication dispensing errors is a significant factor driving the number of adverse drug reactions, which may lead to severe deterioration of the patient’s health and may also lead to death; this is expected to drive the demand in the coming years. For instance, in the U.S., data published by the Institute of Medicine states that around 7,000 deaths each year can be attributed to medication errors.

View summary of this report, Click Here 

Further Key Findings From the Study Suggest:

• The inpatient segment is the leading application segment and occupies the largest share of 74.4% in 2015. Increasing cases of hospitalization coupled with occurrence of large number of medication errors contribute to the growth of this segment. The outpatient segment is expected to be the fastest growing segment during the forecast period with a CAGR of 8.2%.
• The hospitals’ segment is the largest, having a share of around 56.1% in 2015. Retail drug stores and pharmacies are expected to be the fastest growing segment during the forecast period with a CAGR of 7.8%.
• In 2015, the centralized pharmacy segment was the largest operations segment and occupied a share of around 63.4%. The decentralized pharmacy is expected to be the fastest growing segment during the forecast period, with a CAGR of 8.5%.
• In 2015, North America held majority of market share of over 53.8% in global automated dispensing machines market. Increasing medication errors and rising demand for the overall reduction in operational cost by streamlining medication dispensing processes are few key factors attributed to the regions high market share.
• Some of the key market players are Omnicell, Inc.; Becton, Dickinson & Co; Baxter; Swisslog; Parata Systems; AmerisourceBergen Corporation. The other key competitors in the market include Pearson Medical Technologies; Script Pro LLC; and Capsa Solutions.
• Click Here For Access Full Report : https://goo.gl/gzwq8Y

Home Healthcare Market Is Expected To Reach USD 517.2 Billion by 2025

Home healthcare products are generally applied to a broad range of equipment and services designed for exclusive use for home or other non-medical establishments by non-professional caregivers, family members, or the patients themselves.

Increasing adoption of telehealth and other emerging technologies are expected to drive market growth over the forecast period. Home healthcare is rapidly getting adopted as a cost effective alternative to healthcare establishment based therapy and therefore, growing geriatric population base and prevalence of chronic conditions requiring long term care is also expected to have a positive impact on growth. Presence of untapped potential in emerging markets such as India, Brazil and China and increasing health awareness are expected to serve home healthcare market as future growth opportunities.

View summary of this report, Click Here 

Further key findings from the study suggest:

• Home healthcare services dominated the component segment, accounting for over 85.0% of global revenue in 2015.
• Infusion therapy is expected to be the fastest growing services market. Increasing initiatives undertaken by medical service providers to curb costs associated with specialty drugs and by retail pharmacies to render efficient chronic disease management solutions are some of the drivers of this market.
• Home healthcare based diagnostics held lucrative share in the equipment segment accounting around 40.0% in 2015.
• North America was the largest regional market in 2015, accounting for over 40.0% of the revenue. Presence of sophisticated medical systems and reimbursement infrastructure, high patient awareness levels and healthcare expenditure are some of the factors accounting for its substantial share.
• Asia Pacific home healthcare market is expected to grow at the fastest CAGR of around 9.0% from 2016 to 2024 majorly owing to high unmet medical needs coupled with rapidly improving health infrastructure.
• Major players in this vertical include Almost Family Inc., B. Braun Melsungen AG, Abbott Laboratories, Sunrise Medical Inc., 3M Health Care, Baxter, Medtronic, Cardinal Health Inc., Roche diagnostics corp., Air Liquide, Arcadia Health Care, Bayer AG, Amedisys, Inc., Nxstage Medical, Inc., and Arkray Inc.

Click Here For Access Full Report : https://goo.gl/aK1Gi5

Sepsis diagnostics market is expected to reach a value of USD 874.6 million by 2025

Rising prevalence of sepsis is the most significant factor anticipated to drive the market growth during the forecast period.

According to the National Center for Biotechnology Information, the number of patients suffering from septic poisoning rose by an average of 5.7% each year. As a result of this, there is a rising need for early diagnosis of such blood-poisoning diseases amongst patients. High prevalence of sepsis is also leading to a huge mortality rate, which is triggering early diagnosis to execute the clinical intervention.

Rising number of hospital-acquired infections are also expected to support the growth of the market over the forecast period. Hospital-acquired infections majorly include urinary tract & surgical site infections, which result into sepsis. According to WHO, 7 out of every 100 hospitalized patients develop hospital-acquired infections in developed countries. Thus, such infections significantly cause septicemia, which will resultantly raise the need for early diagnosis. On the other hand, pneumonia is also an important driving factor for high demand of sepsis diagnostics as it is one of the major causes for septic shock.

View summary of this report, Click Here 

Further key findings from the study suggest:

• Blood culture media was the largest segment in 2015 due to higher adoption of culture media tests in laboratories for the diagnosis of septic poisoning
• Molecular diagnostics is anticipated to witness lucrative growth over the forecast period due to quick and efficient identification of microorganisms causing septicemia
• Bacterial sepsis contributed toward the largest revenue in 2015. This is due to the fact that bacterial infection is the most common cause for people suffering from septic poisoning
• In 2015, laboratory testing segment held the highest share due to the fact that majority of the sepsis diagnostic tests are being conducted in laboratory-based setting
• North America dominated in 2015 owing to the increasing mortality rate of patients suffering from septicemia
• Some of the key companies include bioMérieux SA, Becton, Dickinson and Company, Thermo Fisher Scientific Inc., Roche Diagnostics, Cepheid Inc., Beckman Coulter, Inc., Nanosphere, Inc., and Bruker Corporation

Click Here For Access Full Report : https://goo.gl/D5I5h0

Portable CT scan and X-ray device market are expected to reach USD 8.41 billion by 2020.

Increasing demand for home healthcare, bedside imaging, and growing use of CT scan to assess the accuracy of medical implants, post interventional medical procedures and anatomical confirmation are key factors driving industry growth.

Rising prevalence of diseases such as cancer, cardiovascular, dental and orthopedic disorder will also augment the growth of the market. Also, an increase in the number of medical implants surgeries owing to unhealthy lifestyle as well as growing base of geriatric population is expected to bolster demand.

The portable X-ray device were dominated by mobile X-ray machines on account of rising demand for core diagnostic and bedside imaging. These device also eliminate the requirement for multiple radiology departments in a healthcare institution, thus promoting industry growth. The handheld X-Ray device market is poised to experience substantial growth over the forecast period owing to high maneuverability and the introduction of products such as NOMAD Pro.

Portable CT scan device market was dominated by the medium slice scanners due to high image resolution capabilities and high usage rates. Medium slice scanner accounted for over 58% of portable CT scan by technology in 2013. Digital radiography, owing to increasing demand for manufacturing filmless X-ray and PACS based radiology device, is identified as the fastest growing technology among the overall market.

View summary of this report, Click Here 

North America is expected to dominate the market demand for these device over the forecast period owing to high expenditure on healthcare, reimbursement framework and sophisticated healthcare infrastructure. However, Asia Pacific is expected to witness the fastest growth, growing at a CAGR of more than 9% owing to improving healthcare infrastructure particularly in emerging economies such as China and India. In addition, the advent of technologically advanced and economical products catering to cost sensitive clientele in the region will fuel the growth of the market.

Supportive government regulations in Asia Pacific promoting manufacturing in the region is expected to drive demand for portable medical machines. Furthermore, low labor cost coupled with abundant tier I companies is projected to propel portable medical machines manufacturing in the region. As a result, product cost is likely to decrease over the forecast period owing to technological advancements which in turn is expected to drive demand, particularly in the emerging economies.

Philips Healthcare was the dominant player in the portable X-ray machines market with a market share of over 17% in 2013. Philips possessed an extensive product portfolio ranging from stationary X-ray systems to digital and portable X-ray systems. Some of the other key players in the industry are Hitachi Medical Systems and Varian Medical Systems, GE Healthcare, and Siemens Healthcare.

Click Here For Access Full Report : https://goo.gl/Y8Yvrt

Osteosynthesis devices market size is expected to reach a value of USD 9.9 billion by 2024

The worldwide prevalence of conditions like osteoporosis and osteomalacia, coupled with heavily occurring road traffic injuries/accidents and sporting injuries support the demand for osteosynthesis devices worldwide.

Osteoporosis, a disease resulting in weakening of bones is responsible for causing more than 8.9 million fractures annually. Forearm, humerus, hip and spine are the most commonly affected areas in patients suffering from the disease. The incidence and economic burden of osteoporosis is increasing worldwide, and patients 65 years old or over are at maximum risk of getting affected.

The geriatric population accounted for 46.2 million in 2014, and is increasingly rising. It is projected that by the year 2060, the number of older population will be twice than that of 2014. The rising incidence of osteoporosis and increasing count of the geriatric population is expected to drive demand for osteosynthesis devices in the coming years.

On the other hand, road traffic deaths are at the focal point of a crisis facing public health and development. The WHO reported that accidents/injuries majorly affect the low- and middle-income countries. Road accidents can cause severe injuries such as broken bones and fractures and requires immediate orthopediccare and attention. 

View summary of this report, Click Here 

Further Key Findings from the Study Suggest:

• North America reported highest revenue growth in this market. U.S. is one of the most lucrative and commercially important markets for orthopedic device manufacturers. Furthermore, technical advancements and a growing aging population (14.5% of the U.S. population), coupled with increasing investments in healthcare sector is estimated to drive growth in the market.
• Asia Pacific is expected to be an attractive region for osteosynthesis devices. Asia Pacific is reported to be at a high risk for osteoporosis because of a reported rise in the elderly population.
• Internal fixation devices held a higher market share than external devices in 2015. Although complications such as infections, consolidation delays, and construct damage are causing concerns, this has indirectly led to the demand for new research and management options in the fight against osteoporosis and fractures.
• The development of absorbable and biocompatible internal bone fixation devices is responsible for leading the drive for constant innovation in the osteosynthesis devices market.
• Some of the key players in this industry include DePuy Synthes, Inc.; Smith & Nephew Plc; Stryker; Zimmer Biomet Holdings, Inc.; Globus Medical, Inc.; GS Medical, LLC; Life Spine, Inc.; MicroPort Orthopedics, Inc.; Néosteo SAS; and Precision Spine, Inc.

Click Here For Access Full Report :  https://goo.gl/BDRZNL

Follw us Linkedin : https://goo.gl/NCe1SW